Travere Therapeutics to Participate at Upcoming Investor Conferences

View Full Press Release
Travere Therapeutics Announces Late-Breaking Data from Phase 3 DUPLEX Study of FILSPARI in FSGS Presented at the American Society of Nephrology (ASN) Kidney Week 2025